ElizabethCooney(Storen)KentMD

Oncology • Fleming Island, FL

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Medical Oncologist/Hematologist with Florida Cancer Specialists in Fleming Island, FL

Join to view full profile

Dr. Kent is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kent's full profile

Already have an account?

Office
4689 US Highway 17 Ste 25
Fleming Island, FL 32003
Phone+1 904-269-6526

Fax+1 904-269-6527

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2001 - 2004
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1998 - 2001
Wayne State University School of MedicineClass of 1998

Certifications & Licensure

FL State Medical License 2013 - 2025
MO State Medical License 2006 - 2014
KS State Medical License 2004 - 2013
MN State Medical License 1999 - 2002
American Board of Internal Medicine Medical Oncology

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery Start of enrollment: 2011 Apr 01
Active, not recruiting
Phase 3
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
Active, not recruiting
Phase 3
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Start of enrollment: 2010 Sep 15
Terminated
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

31 citations
Prospective quality-of-life assessment in patients receiving concurrent gemcitabine and radiotherapy as a bladder preservation strategy.
Joseph M. Herman, David Smith, James E. Montie, James A. Hayman, Molly A. Sullivan
Urology. 2004-07-01
59 citations
Combined-Modality Therapy With Gemcitabine and Radiotherapy As a Bladder Preservation Strategy: Results of a Phase I Trial
Elizabeth C Kent, Howard M. Sandler, James E. Montie, Cheryl T. Lee, Joseph M. Herman
Journal of Clinical Oncology. 2004-07-01
41 citations
Selective palliative transcatheter embolization of bony metastases from renal cell carcinoma
Andrew R. Forauer, Elizabeth C Kent, Wojciech Cwikiel, Peggy S. Esper, Bruce G. Redman
Acta Oncologica. 2007-01-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member